Top Companies in the U.S. AI in Medical Imaging Market

DELHI, India - Oct. 31, 2025 - PRLog -- According to the DPI Research, the United States AI in medical imaging market size was valued at USD 524 million in 2024 and is projected to hit around USD 6,765 million by 2033, growing at a whopping CAGR of 32.8% during the forecast period 2025 to 2033.

The U.S. market for AI in medical imaging is characterized by a diverse array of companies pioneering advanced technologies that enhance diagnostic capabilities. One prominent player is Aidoc, which employs deep learning algorithms to assist radiologists in identifying critical conditions swiftly. Their solutions are designed to integrate seamlessly into existing workflows, significantly improving response times for conditions such as intracranial hemorrhages.

Another key contributor is Viz.ai, known for its innovative approach that utilizes artificial intelligence to facilitate the triage process in stroke care. Their platform effectively analyzes brain scans and alerts specialists within minutes, ultimately leading to timely interventions and better patient outcomes. The incorporation of AI into imaging not only streamlines diagnostics but also enhances the decision-making process for healthcare professionals.

ICAD is also noteworthy, as it focuses on the implementation of AI to detect breast cancer and other malignancies. Their imaging solutions leverage machine learning models that improve the accuracy of radiological assessments, assisting radiologists in making more informed decisions with increased confidence in their evaluations.

HeartFlow stands out in the realm of cardiac imaging by providing non-invasive assessments of coronary artery disease through advanced computational fluid dynamics and AI algorithms. This approach allows for personalized treatment planning by accurately modeling blood flow in individual patients, thereby ensuring a comprehensive evaluation of cardiovascular health.

Other significant players include Zebra Medical Vision, which offers a broad range of imaging analysis tools, and Qure.ai, recognized for its focused solutions aimed at tackling tuberculosis detection through chest radiographs. Each company contributes uniquely to this rapidly evolving market, as they employ distinctive AI methodologies that not only advance imaging capabilities but also strive to achieve better clinical outcomes. This competitive landscape highlights the ongoing innovation and commitment to improving patient care through artificial intelligence in medical imaging.

More Details @ https://dpiresearch.com/report/united-states-ai-in-medica...